NCT00293488
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +31 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
Clinical trial condition
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
120 public trials
51 recruiting studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT01274533
- Conditions
- Adult T Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Columbia University Medical Center New York, United States
NCT02337595
- Conditions
- Bone Marrow Diseases, Bone Marrow Failure Disorders, Bone Marrow Failure Syndromes, +18 more
- Locations
-
- Federal Research Center for pediatric hematology, oncology and immunology Moscow, Russia
Completed
Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
NCT01466881
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +23 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
- The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
NCT00041327
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Siteman Cancer Center at Barnes-Jewish Hospital St Louis, Missouri, United States
NCT00131937
- Conditions
- Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hematologic Diseases, +28 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
NCT00561418
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +22 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00640796
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +19 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Completed
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01129180
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
NCT00006383
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
- Locations
-
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
- University of Illinois at Chicago Chicago, Illinois, United States